Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
The Journal of Clinical Investigation|December 25, 2010
Chemokine antagonism in chronic hepatitis C virus infectionEdgar D Charles, Lynn B DustinAntiviral Therapy|January 17, 2013
Primary, post-primary and non-specific immunoglobulin M responses in HCV infectionLynn B Dustin, Edgar D CharlesKidney International|July 17, 2009
Hepatitis C virus-induced cryoglobulinemiaEdgar D Charles, Lynn B DustinJournal of Immunological Methods|September 30, 2010
A flow cytometry-based strategy to identify and express IgM from VH1-69+ clonal peripheral B cellsEdgar D Charles, Michael I M Orloff, Lynn B DustinPlos One|April 25, 2014
Selection of apoptotic cell specific human antibodies from adult bone marrowCaroline Grönwall, Edgar D Charles, Lynn B Dustin, et al.Arthritis and Rheumatism|June 12, 2013
Somatic hypermutations confer rheumatoid factor activity in hepatitis C virus-associated mixed cryoglobulinemiaEdgar D Charles, Michael I M Orloff, Eiko Nishiuchi, et al.Obesity (Silver Spring, Md.)|December 7, 2018
Pegbelfermin (BMS-986036), PEGylated FGF21, in Patients with Obesity and Type 2 Diabetes: Results from a Randomized Phase 2 StudyEdgar D Charles, Brent A Neuschwander-Tetri, Juan Pablo Frias, et al.Hepatology (Baltimore, Md.)|July 30, 2011
Hepatitis C virus induces interferon-λ and interferon-stimulated genes in primary liver culturesSvetlana Marukian, Linda Andrus, Timothy P Sheahan, et al.Hepatology (Baltimore, Md.)|November 13, 2008
Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cellsSvetlana Marukian, Christopher T Jones, Linda Andrus, et al.Clinical and Translational Science|September 1, 2023
Pharmacokinetics, safety, and tolerability of BMS-986263, a lipid nanoparticle containing HSP47 siRNA, in participants with hepatic impairmentHisham Qosa, Claudia H M C de Oliveira, Giovanni Cizza, et al.Pageof 3